文献速递乳腺癌

乳腺分泌性癌的临床病理特征分析

[Clinicopathologic features of secretory breast carcinoma].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

该研究收集3例乳腺分泌性癌(SCB)病例,采用免疫组化SP法检测ER、PR、HER-2、Ki-67、S100、CK5/6、p63、SMA、calponin、GCDFP-15和EGFR表达,并用FISH检测ETV6-NTRK3融合基因。结果显示SCB为低级别三阴性乳腺癌,3例均检出ETV6-NTRK3融合基因,临床过程惰性、预后好。

要点

  • SCB为罕见低级别三阴性乳腺癌,ER/PR多阴性或局灶弱阳性,HER-2阴性。
  • S100、CK5/6、EGFR弥漫强阳性,SMA、calponin、GCDFP-15阴性有助诊断。
  • ETV6-NTRK3融合基因是SCB特征性分子改变,3例均检出。

核心结论

  • SCB是一种罕见的低级别特殊类型三阴性乳腺癌,具有独特病理形态学特征和特征性ETV6-NTRK3融合基因,临床过程惰性、预后好。

研究设计与样本

  • 收集3例SCB临床资料,采用免疫组化SP法检测ER、PR、HER-2、Ki-67、S100、CK5/6、p63、SMA、calponin、GCDFP-15和EGFR表达,采用FISH检测ETV6-NTRK3融合基因。

主要发现

  • 例1和例2 ER局灶弱阳性约5%,例3 ER阴性;例1 PR局灶弱阳性约5%,例2和例3 PR阴性。
  • 3例均HER-2阴性、S100弥漫强阳性、CK5/6阳性、SMA阴性、calponin阴性、GCDFP-15阴性、EGFR阳性。
  • Ki-67指数例1为15%、例2为15%、例3为10%。
  • p63例1大部分肿瘤细胞阴性、局灶区域细胞核和细胞质阳性;例2完全阴性;例3细胞质阳性及部分分泌物阳性着色。
  • 3例均成功检测出ETV6-NTRK3融合基因。

临床怎么用

  • 对三阴性乳腺癌伴S100、CK5/6、EGFR弥漫强阳性且SMA、calponin、GCDFP-15阴性者,应警惕SCB并行ETV6-NTRK3融合基因检测。

局限性

  • 样本量仅3例,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: Investigate the clinicopathological features for secretory carcinoma of breast (SCB). Methods: The clinical data of 3 SCB cases were collected, immunohistochemical staining was performed by the streptavidin-peroxidase (SP) method to test the expression of the antibodies: ER, PR, HER-2, Ki-67, S100, CK5/6, p63, SMA, calponin, GCDFP-15, and EGFR. Fluorescence in situ hybridization (FISH) was used to detect the ETV6-NTRK3 gene fusion. Results: ER was focal weakly positive in case 1 and case 2 (about 5%) , and negative in case 3. PR was focal weakly positive in case 1 (about 5%) and completely negative in case 2 and case 3. Three cases showed that HER-2, SMA, calponin, GCDFP-15 were negative, while S100, CK5/6, EGFR were diffuse strongly positive. The proliferation index was nearly 15% in case 1 and case 2, and 10% in case 3. p63 was negative in mostly tumor cells of case 1, and focal positive expression in the nucleus and cytoplasm. In case 2, p63 was completely negative. However, p63 was observed positive in the cytoplasm as well as some secretory material in case 3. ETV6-NTRK3 gene fusion detection by FISH was positive in all cases. Conclusions: SCB is a rare low grade triple-negative breast cancer with the unique pathomorphologic features, while its recurrent t (12; 15) (p13; q25) translocation resulting in ETV6 -NTRK3 gene fusion. It has the indolent clinical behavior and good prognosis. 目的: 探讨乳腺分泌性癌(SCB)的临床病理特征。 方法: 收集3例SCB的临床资料,采用免疫组化SP法检测雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER-2)、Ki-67、S100、CK5/6、p63、平滑肌肌动蛋白(SMA)、钙调理蛋白(calponin)、巨囊性病液体蛋白15(GCDFP-15)和表皮生长因子受体(EGFR)等的表达情况,采用荧光原位杂交技术检测ETS变异基因6-神经酪氨酸激酶受体3(ETV6-NTRK3)融合基因。 结果: 例1和例2 ER(局灶弱+,约5%),例3 ER(-);例1 PR(局灶弱+,约5%),例2和例3 PR (-);3例均HER-2(-),S100(弥漫强+),CK5/6(+),SMA(-),calponin(-), GCDFP-15(-),EGFR(+)。例1 Ki-67指数为15%,例2为15%,例3为10%。例1大部分肿瘤细胞p63(-)、局灶区域细胞核(+)、局灶区域细胞质(+);例2 p63(-),例3肿瘤细胞p63染色细胞质(+)、部分分泌物阳性着色。3例均成功检测出ETV6-NTRK3融合基因。 结论: SCB是一种罕见的低级别特殊类型三阴性乳腺癌,具有独特的病理形态学特征,分子遗传学上具有特征性t(12;15) (p13;q25)平衡易位,产生ETV6-NTRK3融合基因,临床过程惰性,预后好。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang F, Shi M, Liao Q, et al. [Clinicopathologic features of secretory breast carcinoma]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31434456. doi:10.3760/cma.j.issn.0253-3766.2019.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。